廣告
香港股市 將在 7 小時 53 分鐘 開市

  • 恒指

    18,578.30
    +102.38 (+0.55%)
     

  • 國指

    6,572.45
    +25.16 (+0.38%)
     

  • 上證綜指

    3,140.72
    +35.90 (+1.16%)
     

  • 道指

    38,795.33
    +119.65 (+0.31%)
     

  • 標普 500

    5,162.14
    +34.35 (+0.67%)
     

  • 納指

    16,272.61
    +116.28 (+0.72%)
     

  • Vix指數

    13.79
    +0.30 (+2.22%)
     

  • 富時100

    8,213.49
    +41.34 (+0.51%)
     

  • 紐約期油

    78.29
    +0.18 (+0.23%)
     

  • 金價

    2,331.30
    +22.70 (+0.98%)
     

  • 美元

    7.8164
    +0.0061 (+0.08%)
     

  • 人民幣

    0.9216
    -0.0048 (-0.52%)
     

  • 日圓

    0.0505
    -0.0003 (-0.55%)
     

  • 歐元

    8.4218
    +0.0155 (+0.18%)
     

  • Bitcoin

    63,039.64
    -1,339.10 (-2.08%)
     

  • CMC Crypto 200

    1,366.50
    +53.87 (+4.10%)
     

Teladoc (TDOC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Equity Research
·2 分鐘文章

For the quarter ended March 2024, Teladoc (TDOC) reported revenue of $646.13 million, up 2.7% over the same period last year. EPS came in at -$0.49, compared to -$0.37 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $636.98 million, representing a surprise of +1.44%. The company delivered an EPS surprise of -4.26%, with the consensus EPS estimate being -$0.47.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

廣告

Here is how Teladoc performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • U.S. Integrated Care Members: 91.8 million versus the five-analyst average estimate of 89.85 million.

  • BetterHelp Paying Users: 0.42 million versus 0.43 million estimated by five analysts on average.

  • Chronic Care Program Enrollment: 1.12 million compared to the 1.13 million average estimate based on four analysts.

  • Average Revenue Per U.S. Integrated Care Member: $1.38 compared to the $1.38 average estimate based on four analysts.

  • Visits: 4,600,000 compared to the 5,056,574 average estimate based on two analysts.

  • Revenues by Segment- Teladoc Health Integrated Care: $377.11 million versus the seven-analyst average estimate of $370.07 million.

  • Revenues by Segment- BetterHelp: $269.02 million compared to the $267.37 million average estimate based on seven analysts.

  • Revenues by Segment- BetterHelp- Other Wellness Services: $5.31 million versus the three-analyst average estimate of $4.46 million.

  • Revenues by Segment- BetterHelp- Therapy Services: $263.71 million compared to the $261.88 million average estimate based on three analysts.

  • Revenue by Type- Other: $88.96 million versus $82.25 million estimated by two analysts on average.

  • Revenue by Type- Access fees: $557.17 million compared to the $555.17 million average estimate based on two analysts.

  • Adjusted EBITDA- BetterHelp: $15.47 million versus $15.44 million estimated by four analysts on average.

View all Key Company Metrics for Teladoc here>>>

Shares of Teladoc have returned -10.1% over the past month versus the Zacks S&P 500 composite's -3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Teladoc Health, Inc. (TDOC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research